Approvals Granted to Begin LYS-GM101 Clinical Trial for GM1 Gangliosidosis
source: pixabay.com

Approvals Granted to Begin LYS-GM101 Clinical Trial for GM1 Gangliosidosis

In an exciting press release, gene therapy platform company Lysogene announced that it had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) and Research Ethics Committee. As…

Continue Reading Approvals Granted to Begin LYS-GM101 Clinical Trial for GM1 Gangliosidosis
DNMT3B Gene May Cause Pulmonary Hypertension, PAH Development
https://pixabay.com/en/stars-heart-love-mom-mother-443900/

DNMT3B Gene May Cause Pulmonary Hypertension, PAH Development

Recently, Pulmonary Hypertension News shared some burgeoning medical news: that the DNMT3B gene has now been linked to the development of pulmonary hypertension (PH) and a rare form of chronic high blood…

Continue Reading DNMT3B Gene May Cause Pulmonary Hypertension, PAH Development
Study Reveals Gene Therapy as a Possible Tuberous Sclerosis Complex Treatment
source: pixabay.com

Study Reveals Gene Therapy as a Possible Tuberous Sclerosis Complex Treatment

According to a story from news-medical.net, a team of scientists affiliated with Massachusetts General Hospital has conducted a study revealing that gene therapy could be an effective treatment for tuberous…

Continue Reading Study Reveals Gene Therapy as a Possible Tuberous Sclerosis Complex Treatment